Ohsawa M, Kimura H
Department of Legal Medicine, Kurume University School of Medicine, Fukuoka, Japan.
Biochim Biophys Acta. 1989 Aug 18;992(2):195-200. doi: 10.1016/0304-4165(89)90010-x.
After the addition of actin to serum, the binding of actin to serum actin-binding proteins was analyzed by the method of immunoblotting using monospecific antibodies against vitamin D-binding protein (DBP) (group-specific component, Gc), human skeletal actin and human plasma gelsolin. When increasing amounts of globular actin were added to serum, actin bound to DBP preferentially. After exhausting DBP, actin began to bind to plasma gelsolin. When equally increasing amounts of filamentous actin were added to serum, actin was bound to both plasma gelsolin and DBP, and then uncomplexed DBP removed one actin molecule from gelsolin-actin 1:2 complex, resulting in a gelsolin-actin 1:1 complex. These results support the theory that the actin-depolymerizing activity of serum is due to the concerted role of plasma gelsolin and DBP.
向血清中添加肌动蛋白后,采用免疫印迹法,使用针对维生素D结合蛋白(DBP)(组特异性成分,Gc)、人骨骼肌肌动蛋白和人血浆凝溶胶蛋白的单特异性抗体,分析肌动蛋白与血清肌动蛋白结合蛋白的结合情况。当向血清中添加越来越多的球状肌动蛋白时,肌动蛋白优先与DBP结合。耗尽DBP后,肌动蛋白开始与血浆凝溶胶蛋白结合。当向血清中添加等量增加的丝状肌动蛋白时,肌动蛋白与血浆凝溶胶蛋白和DBP都结合,然后未结合的DBP从凝溶胶蛋白-肌动蛋白1:2复合物中去除一个肌动蛋白分子,形成凝溶胶蛋白-肌动蛋白1:1复合物。这些结果支持了血清中肌动蛋白解聚活性是由于血浆凝溶胶蛋白和DBP协同作用的理论。